GREY:MDCGF - Post by User
Post by
Indicatoron Apr 02, 2012 1:11pm
300 Views
Post# 19748424
I'm buying down here
I'm buying down here Corporate Outlook
Expected upcoming milestones include:
- Initiation of a Phase I clinical trial for a one-dose H5N1 VLP vaccine with a new adjuvant in the second quarter of 2012, in partnership with the Infectious Disease Research Institute (IDRI), with interim data expected in the second half of this year
- Completion of the final two milestones related to the DARPA Technology Investment Agreement.
- Results of US Phase IIa clinical trial with quadrivalent seasonal vaccine in the first quarter of 2013
- Potential contracts (government, pharmaceutical companies)
- Addition of new pipeline candidates
I'm buying some down here on pullbacks.